Location History:
- New Brighton, MN (US) (1985 - 2001)
- North Oaks, MN (US) (2000 - 2023)
Company Filing History:
25 out of 8,742 
3 out of 3 
1 out of 22 
Years Active: 1985-2023
Title: **Innovations of John G. Keimel: Pioneering Biologic Agent Distribution Systems**
Introduction
John G. Keimel, an accomplished inventor based in North Oaks, MN, has made significant contributions to the field of medical technology, particularly in the delivery of therapeutic agents to the central nervous system. With an impressive portfolio of 30 patents, Keimel has demonstrated a commitment to enhancing healthcare solutions through innovative inventions.
Latest Patents
One of Keimel's latest patents delves into "Systems and methods for enhanced distribution of a biologic agent within the brain and spinal cord." This invention discusses various systems and methods designed for the effective delivery of biologic agents to the central nervous system (CNS). Notably, the method includes injecting a therapeutic agent into a cerebrospinal fluid (CSF) region of a subject and establishing fluid communication between a fluid reservoir and a second CSF region. The fluid is maintained at a hydraulic pressure at or above intracranial pressure, supplemented by the infusion of a hyperosmotic fluid systemically. This patent also encompasses various embodiments alongside kits and systems aimed at improving therapeutic delivery.
Career Highlights
Throughout his career, John G. Keimel has worked with renowned companies, including Medtronic, Inc. and New Hope Research Foundation, Inc. His experience in these institutions has allowed him to develop and refine his innovative approaches to solving complex medical challenges related to CNS therapies.
Collaborations
Keimel's work has also involved close collaborations with notable coworkers such as Terrell M. Williams and Timothy G. Laske. These professional relationships have fostered a productive environment for innovation, leading to advancements in the distribution of therapeutic agents.
Conclusion
John G. Keimel exemplifies the spirit of innovation within the medical technology sector. With a focus on enhancing the delivery of therapeutic agents to the CNS, his work continues to influence the development of effective treatment methods. As he progresses in his career, his contributions promise to impact countless lives, reflecting the importance of ingenuity in healthcare.